longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Cronos

CRON

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Cronos (CRON)

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and intern...

Open
--
High
--
Low
--
Prev. Close
--
Volume
--
Turnover
--
Avg Price
--
Bid/Ask Ratio
--
Amplitude
--
52wk High
--
Volume Ratio
--
Turnover Ratio
--
52wk Low
--
Float Mkt Cap
--
Market Cap
--
P/ETTM
--
P/EDynamic
--
P/EStatic
--
EPSTTM
--
EPSDynamic
--
EPSStatic
--
BVPS
--
P/B
--
Circulating Supply
--
Dividend YieldTTM
--
DividendTTM
--
Shares
--
Min lot size
--
Currency
--

Cronos Analyst Rating

View more

Forecast & Rating

Sep 25, 2026
Price forecast
$2.50-26.26%
Forecast & RatingBuy
4analysts
  • Strong buy75.00%
  • Buy0.00%
  • Hold25.00%
  • Sell0.00%
  • Strong sell0.00%
Strong buy
3
Buy
0
Hold
1
Sell
0
Strong sell
0

News

  • MarketWatch Automated · Sep 24 at 09:20 PM

    Cronos Group Inc. Stock Falls Thursday, Underperforms Market

  • Quartr · Sep 24 at 04:54 PM

    CRON: Genetics-driven innovation and brand leadership have propelled rapid, peer-beating growth

  • PUBT · Sep 24 at 12:01 PM

    Cronos Group hosts first Investor Day webcast

  • MarketWatch Automated · Sep 22 at 09:19 PM

    Cronos Group Inc. Stock Rises Tuesday, Outperforms Market

  • Coindar · Sep 19 at 07:34 PM

    Cronos to Host Meetup in Rome on September 26th

Posts

View more

Bullish vs. Bearish — Last 3 Months

234 followers · 0 opinions
H
▲Bullish50%
50%Bearish▼
  • H
    Hardik ShahApr 23 at 12:37 PM

    📢 𝐉𝐔𝐒𝐓 𝐈𝐍: U.S. Reclassifies Medical Marijuana to Schedule III - AP

    $Tilray Brands(TLRY.US) $SNDL(SNDL.US) $Organigram(OGI.US) $MSOS $TRUL $Aurora Cannabis(ACB.US) $Cronos(CRON.US) $Canopy Growth(CGC.US)

    👉 𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬:

    ➤ Trump administration moves medical marijuana to 𝐒𝐜𝐡𝐞𝐝𝐮𝐥𝐞 𝐈𝐈𝐈.

    ➤ Shift reclassifies cannabis from 𝐒𝐜𝐡𝐞𝐝𝐮𝐥𝐞 𝐈 status.

    ➤ Change applies to 𝐬𝐭𝐚𝐭𝐞-𝐥𝐢𝐜𝐞𝐧𝐬𝐞𝐝 medical marijuana operators.

    ➤ Does not fully 𝐥𝐞𝐠𝐚𝐥𝐢𝐳𝐞 cannabis at federal level.

    ➤ Opens door to expanded 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 and medical use.

    ➤ Provides potential 𝐭𝐚𝐱 𝐫𝐞𝐥𝐢𝐞𝐟 for cannabis businesses.

    ➤ Marks major shift in U.S. 𝐝𝐫𝐮𝐠 𝐩𝐨𝐥𝐢𝐜𝐲 and regulation.

    Source: Hardik Shah